Sentence examples for a favourable risk from inspiring English sources

Furthermore, the percentage of obese subjects with a favourable risk profile decreases with increasing age in all cohorts.

Pioglitazone also had a favourable risk profile compared with rosiglitazone; although this requires replication in other studies, it may have implications for prescribing within this class of drugs.

Pioglitazone was associated with reduced all cause mortality compared with metformin, and it had a favourable risk profile compared with rosiglitazone, which requires replication in other studies.

Etanercept either alone or added to existing sulfasalazine therapy is associated with a favourable risk benefit profile, thus broadening the range of options for the treatment of patients with active RA.

In a UK retrospective cohort study, pioglitazone was associated with a lower risk of all-cause mortality than metformin and a favourable risk profile vs rosiglitazone [ 36].Nathan et al. [ 2] note well publicised meta-analysis data suggesting an increased risk of myocardial infarction with rosiglitazone [ 59, 60] and advise against its use [ 2].

In summary, results of the RAPID-axSpA trial demonstrate that treatment with both CZP-dosing regimens (200 mg Q2W or 400 mg Q4W) is clinically effective with a favourable risk benefit profile up to 24 weeks in patients with active axSpA.

Drug regulatory agencies in various countries attempt to rely on premarketing scientific studies of the effects of drugs in animals and humans in order to determine if new drugs have a favourable risk-to-benefit ratio.

PEGylation and increasing the specific activity enhance the pharmacokinetic properties of a 177Lu-labelled BN-based radiopharmaceutical and provide a protocol for targeted radionuclide therapy with a beneficial anti-tumour effectiveness and a favourable risk-profile at the same time.

On the basis of the ease of use and lack of AE concerns associated with nVNS in the current study, the device appears to have a favourable risk-benefit profile in MM/MRM that is appropriate for further evaluation.

PEGylation, increasing the specific activity of the radiolabelled bombesin analogue and shortening the injection interval proved to be effective strategies to enhance the radiotherapeutic efficacy and to provide a favourable risk-profile at the same time.

CZP+MTX had a favourable risk-benefit profile over 5 years of treatment in active RA patients.